Corporate Europe Observatory

Exposing the power of corporate lobbying in the EU

  • Dansk
  • NL
  • EN
  • FI
  • FR
  • DE
  • EL
  • IT
  • NO
  • PL
  • PT
  • RO
  • SL
  • ES
  • SV

Profiting from injustice

How law firms, arbitrators and financiers are fuelling an investment arbitration boom

A small club of international law firms, arbitrators and financial speculators are fuelling an investment arbitration boom that is costing taxpayers billions of dollars and preventing legislation in the public interest, according to a new report from the Transnational Institute and Corporate Europe Observatory.

Investment arbitration cases are brought by foreign investors against governments following alleged breaches of international investment agreements. Emblematic cases include tobacco giant Philip Morris suing Uruguay and Australia over health warnings on cigarette packets; and Swedish energy multinational Vattenfall seeking $3.7bn from Germany following that country’s decision to phase-out nuclear energy.

Profiting from Injustice uncovers a secretive but burgeoning legal industry which benefits from these disputes – at the expense of taxpayers, the environment and human rights. Law firms and arbitrators, who are making millions from investment disputes against governments, are actively promoting new cases and lobbying against reform in the public interest.

Download a PDF of the full report:
 

Attached files: 
Tag: 
Partner organisation: 
 

The corporate lobby tour

Publicly, business lobby groups are heavily pushing the idea that TTIP will benefit small and medium-sized enterprises (SMEs). But behind closed doors they admit the reality: that small companies will “face increased competition” and that “benefits remain hypothetical”.
Law firms and their stake in TTIP
The prospective EU-US trade deal could be the world's biggest such treaty. The revolving door between public and private sectors is helping to grease the wheels of the TTIP corporate lobby.
Policy prescriptions: the firepower of the EU pharmaceutical lobby and implications for public health
A citizen's tour of corporate power in Brussels 03/09/15
Big money and close ties behind Big Pharma's Brussels lobby efforts – new study

Stop the Crop

Alternative Trade Mandate